Leaderboards/Urinary Bladder and Prostate Research

Urinary Bladder and Prostate Research

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Anne P. Cameron
University of Michigan
2
Runchun Huang
First Hospital of Lanzhou University
3
Yu‐Chen Chen
Kaohsiung Medical University
4
Yutao Lou
Zhejiang Provincial People's Hospital
5
Laura Schwartz
Nationwide Children's Hospital
6
Baian Wei
Guangzhou University of Chinese Medicine
7
Young-Soo Lim
Pohang University of Science and Technology
8
Alp Timuçin Toymuş
Koç University
9
Evan Garden
Icahn School of Medicine at Mount Sinai
10
Freya Bull
University College London

Papers

1
The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder
The Journal of Urology|2024
171 cit.
2
Diabetes-induced male infertility: potential mechanisms and treatment options
Molecular Medicine|2024
90 cit.
3
The mechanism of action of <i>Botrychium (Thunb.) Sw.</i> for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics
Journal of Pharmacy and Pharmacology|2024
49 cit.
4
Publication in Scientific Reports (2024) [49 citations, W4399205353]
Scientific Reports|2024
49 cit.
5
An integrated and flexible ultrasonic device for continuous bladder volume monitoring
Nature Communications|2024
44 cit.
6
Publication in BMC Public Health (2024) [18 citations, W4392851520]
BMC Public Health|2024
18 cit.
7
Insulin receptor signaling engages bladder urothelial defenses that limit urinary tract infection
Cell Reports|2024
13 cit.
8
Publication in Proceedings of the National Academy of Sciences (2024) [12 citations, W4400408213]
Proceedings of the National Academy of Sciences|2024
12 cit.
9
Publication in Nature Communications (2025) [11 citations, W4409837160]
Nature Communications|2025
11 cit.
10
Publication in Scientific Reports (2024) [10 citations, W4399274550]
Scientific Reports|2024
10 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
MP Chlebicki
Singapore General Hospital
2
Budiwan Sumarsono
Astellas Pharma (Japan)
3
Paul N. Mudd
United Therapeutics (United States)
4
Bernie T. Haylen
UNSW Sydney
5
Mark Taratkin
Institute for Reproductive Health
6
M Ashworth Dirac
Institute for Health Metrics and Evaluation
7
Şaban Oğuz Demirdöğen
Erzurum Regional Training and Research Hospital
8
Xianguo Chen
Jinhua Central Hospital
9
Tim M. Bruns
University of Michigan
10
Weiqun Yu
Beth Israel Deaconess Medical Center

Papers

1
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
˜The œLancet. Gastroenterology & hepatology|2022
797 cit.
2
The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
The Lancet Healthy Longevity|2022
250 cit.
3
Thulium Fiber Laser: Bringing Lasers to a Whole New Level
European Urology Open Science|2022
22 cit.
4
NLRP3-mediated IL-1β in regulating the imbalance between Th17 and Treg in experimental autoimmune prostatitis
Scientific Reports|2024
18 cit.
5
Smooth Muscle Insulin Receptor Deletion Causes Voiding Dysfunction: A Mechanism for Diabetic Bladder Dysfunction
Diabetes|2022
17 cit.
6
Thulium fiber laser in urology: physics made simple.
PubMed|2022
14 cit.
7
Closed-loop sacral neuromodulation for bladder function using dorsal root ganglia sensory feedback in an anesthetized feline model
Medical & Biological Engineering & Computing|2022
14 cit.
8
Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial
International Journal of Clinical Practice|2022
14 cit.
9
Thulium fiber laser vs Ho:YAG in RIRS: a prospective randomized clinical trial assessing the efficacy of lasers and different fiber diameters (150 µm and 200 µm)
World Journal of Urology|2023
12 cit.
10
Tibial nerve stimulation increases vaginal blood perfusion and bone mineral density and yield load in ovariectomized rat menopause model
International Urogynecology Journal|2022
10 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Alan Wein
University of Miami
2
William C. de Groat
University of Pittsburgh
3
Paul Abrams
Southmead Hospital
4
Hann‐Chorng Kuo
Tzu Chi University
5
Michael B. Chancellor
Oakland University
6
Scott J. Hultgren
Washington University in St. Louis
7
Karl‐Erik Andersson
Forest Institute
8
Robert M. Levin
Albany College of Pharmacy and Health Sciences
9
Alan J. Wein
University of Miami
10
Jean de la Rosette
Radboud University Nijmegen

Papers

1
The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society
Neurourology and Urodynamics|2002
8.3k cit.
2
Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
European Urology|2006
2.6k cit.
3
ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence
Neurourology and Urodynamics|2004
2k cit.
4
Role of <i>Escherichia coli</i> Curli Operons in Directing Amyloid Fiber Formation
Science|2002
1.3k cit.
5
Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections
Science|2003
1.2k cit.
6
6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: EVALUATION AND TREATMENT OF URINARY INCONTINENCE, PELVIC ORGAN PROLAPSE AND FAECAL INCONTINENCE
Neurourology and Urodynamics|2018
1.1k cit.
7
The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the international continence society
American Journal of Obstetrics and Gynecology|2002
1k cit.
8
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction
British Journal of Urology|2011
1k cit.
9
Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic <i>Escherichia coli</i>
Science|1998
952 cit.
10
Establishment of a Persistent <i>Escherichia coli</i> Reservoir during the Acute Phase of a Bladder Infection
Infection and Immunity|2001
858 cit.

Reagents for Urinary Bladder and Prostate Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling TechnologyEvidence 61

Versican (F4U1K) Rabbit Monoclonal Antibody

Cited in 6 papers
#98586$161,376
View Evidence →
Cell Signaling TechnologyEvidence 60

PathScan® RP Neurofilament-H Sandwich ELISA Kit

#10204$67,830,490
View Evidence →

⭐ Top Rated

Best all-around

Cytek Biosciences

PE Anti-Mouse CD274 (PD-L1, B7-H1) (10F.9G2)

#50-1243
View Evidence →
Cell Signaling TechnologyEvidence 67

Phospho-Tyrosine (P-Tyr-1000) MultiMab® Rabbit Monoclonal Antibody mix (Magnetic Bead Conjugate)

#14017$446
View Evidence →
Cell Signaling TechnologyEvidence 66

CD38 (E9F5A) Rabbit Monoclonal Antibody (Alexa Fluor® 555 Conjugate)

#52005$465
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 61

Versican (F4U1K) Rabbit Monoclonal Antibody

Cited in 6 papers
#98586$161,376
View Evidence →
Cell Signaling TechnologyEvidence 61

Phospho-FoxM1 (Ser35) Antibody

#14170$362
View Evidence →
Cell Signaling TechnologyEvidence 64

Cathepsin K (E7U5N) Rabbit Monoclonal Antibody (BSA and Azide Free)

#89623$865
View Evidence →